218 related articles for article (PubMed ID: 32396524)
1. Pluronic P123 modified nano micelles loaded with doxorubicin enhanced tumor-suppressing effect on drug-resistant breast cancer cells.
Zhang X; Chen W; Bai J; Jin L; Kang X; Zhang H; Wang Z
Aging (Albany NY); 2020 May; 12(9):8289-8300. PubMed ID: 32396524
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of inhibition of P-glycoprotein mediated efflux by Pluronic P123/F127 block copolymers: relationship between copolymer concentration and inhibitory activity.
Wei Z; Yuan S; Hao J; Fang X
Eur J Pharm Biopharm; 2013 Feb; 83(2):266-74. PubMed ID: 23089310
[TBL] [Abstract][Full Text] [Related]
3. Transferrin receptor-targeted pH-sensitive micellar system for diminution of drug resistance and targetable delivery in multidrug-resistant breast cancer.
Gao W; Ye G; Duan X; Yang X; Yang VC
Int J Nanomedicine; 2017; 12():1047-1064. PubMed ID: 28223798
[TBL] [Abstract][Full Text] [Related]
4. pH-sensitive pluronic micelles combined with oxidative stress amplification for enhancing multidrug resistance breast cancer therapy.
Cheng X; Zeng X; Zheng Y; Fang Q; Wang X; Wang J; Tang R
J Colloid Interface Sci; 2020 Apr; 565():254-269. PubMed ID: 31978788
[TBL] [Abstract][Full Text] [Related]
5. Dual ligand-targeted Pluronic P123 polymeric micelles enhance the therapeutic effect of breast cancer with bone metastases.
Gao H; Zhang J; Kleijn TG; Wu Z; Liu B; Ma Y; Ding B; Yin D
Oncol Res; 2024; 32(4):769-784. PubMed ID: 38560569
[TBL] [Abstract][Full Text] [Related]
6. Selective Photodynamic Effects on Breast Cancer Cells Provided by p123 Pluronic®- Based Nanoparticles Modulating Hypericin Delivery.
Damke GMZF; Souza RP; Montanha MC; Damke E; Gonçalves RS; César GB; Kimura E; Caetano W; Hioka N; Consolaro MEL
Anticancer Agents Med Chem; 2020; 20(11):1352-1367. PubMed ID: 30387402
[TBL] [Abstract][Full Text] [Related]
7. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
[TBL] [Abstract][Full Text] [Related]
8. Pluronic-based functional polymeric mixed micelles for co-delivery of doxorubicin and paclitaxel to multidrug resistant tumor.
Chen Y; Zhang W; Huang Y; Gao F; Sha X; Fang X
Int J Pharm; 2015 Jul; 488(1-2):44-58. PubMed ID: 25899286
[TBL] [Abstract][Full Text] [Related]
9. Active-targeting and acid-sensitive pluronic prodrug micelles for efficiently overcoming MDR in breast cancer.
Xu C; Xu J; Zheng Y; Fang Q; Lv X; Wang X; Tang R
J Mater Chem B; 2020 Apr; 8(13):2726-2737. PubMed ID: 32154530
[TBL] [Abstract][Full Text] [Related]
10. Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin.
Qiu L; Qiao M; Chen Q; Tian C; Long M; Wang M; Li Z; Hu W; Li G; Cheng L; Cheng L; Hu H; Zhao X; Chen D
Biomaterials; 2014 Dec; 35(37):9877-9887. PubMed ID: 25201738
[TBL] [Abstract][Full Text] [Related]
11. Mixed Micelles of Doxorubicin Overcome Multidrug Resistance by Inhibiting the Expression of P-Glycoprotein.
Jin Y; Zhang Z; Zhao T; Liu X; Jian L
J Biomed Nanotechnol; 2015 Aug; 11(8):1330-8. PubMed ID: 26295136
[TBL] [Abstract][Full Text] [Related]
12. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
Zhang ZL; Jiang QC; Wang SR
Breast Cancer; 2018 Mar; 25(2):233-242. PubMed ID: 29181822
[TBL] [Abstract][Full Text] [Related]
13. Pluronic micelles with suppressing doxorubicin efflux and detoxification for efficiently reversing breast cancer resistance.
Cheng X; Lv X; Xu J; Zheng Y; Wang X; Tang R
Eur J Pharm Sci; 2020 Apr; 146():105275. PubMed ID: 32087259
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin derivative loaded acetal-PEG-PCCL micelles for overcoming multidrug resistance in MCF-7/ADR cells.
Zhong XC; Xu WH; Wang ZT; Guo WW; Chen JJ; Guo NN; Wang TT; Lin MT; Zhang ZT; Lu YY; Yang QY; Han M; Xu DH; Gao JQ
Drug Dev Ind Pharm; 2019 Sep; 45(9):1556-1564. PubMed ID: 31271317
[No Abstract] [Full Text] [Related]
15. Dual subcellular compartment delivery of doxorubicin to overcome drug resistant and enhance antitumor activity.
Song YF; Liu DZ; Cheng Y; Liu M; Ye WL; Zhang BL; Liu XY; Zhou SY
Sci Rep; 2015 Nov; 5():16125. PubMed ID: 26530454
[TBL] [Abstract][Full Text] [Related]
16. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
Gu J; Fang X; Hao J; Sha X
Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
[TBL] [Abstract][Full Text] [Related]
17. Formulation and in vitro evaluation of quercetin loaded polymeric micelles composed of pluronic P123 and D-a-tocopheryl polyethylene glycol succinate.
Zhao L; Shi Y; Zou S; Sun M; Lil L; Zhail G
J Biomed Nanotechnol; 2011 Jun; 7(3):358-65. PubMed ID: 21830476
[TBL] [Abstract][Full Text] [Related]
18. CD20 monoclonal antibody targeted nanoscale drug delivery system for doxorubicin chemotherapy: an in vitro study of cell lysis of CD20-positive Raji cells.
Jiang S; Wang X; Zhang Z; Sun L; Pu Y; Yao H; Li J; Liu Y; Zhang Y; Zhang W
Int J Nanomedicine; 2016; 11():5505-5518. PubMed ID: 27843311
[TBL] [Abstract][Full Text] [Related]
19. Small-molecule synthetic compound norcantharidin reverses multi-drug resistance by regulating Sonic hedgehog signaling in human breast cancer cells.
Chen YJ; Kuo CD; Chen SH; Chen WJ; Huang WC; Chao KS; Liao HF
PLoS One; 2012; 7(5):e37006. PubMed ID: 22615870
[TBL] [Abstract][Full Text] [Related]
20. Amphiphilic Copolymeric Micelles for Doxorubicin and Curcumin Co-Delivery to Reverse Multidrug Resistance in Breast Cancer.
Lv L; Qiu K; Yu X; Chen C; Qin F; Shi Y; Ou J; Zhang T; Zhu H; Wu J; Liu C; Li G
J Biomed Nanotechnol; 2016 May; 12(5):973-85. PubMed ID: 27305819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]